SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE was reported 21626 times

These side effects are most commonly reported by patients taking SITAGLIPTIN AND METFORMIN HYDROCHLORIDE:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 1511
1 DIARRHOEA 1398
2 NAUSEA 1111
3 DRUG INEFFECTIVE 1008
4 FATIGUE 902
5 ACUTE KIDNEY INJURY 838
6 VOMITING 781
7 WEIGHT DECREASED 718
8 DIZZINESS 639
9 PANCREATITIS 626
10 DYSPNOEA 623
11 NO ADVERSE EVENT 623
12 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 617
13 PRODUCT DOSE OMISSION ISSUE 614
14 DEATH 606
15 OFF LABEL USE 601
16 PANCREATIC CARCINOMA 588
17 HEADACHE 586
18 ASTHENIA 572
19 LACTIC ACIDOSIS 566
20 MALAISE 521
21 PAIN 517
22 FALL 472
23 PRURITUS 468
24 HYPERTENSION 459
25 ARTHRALGIA 458
26 ABDOMINAL PAIN 434
27 DIABETES MELLITUS INADEQUATE CONTROL 423
28 DECREASED APPETITE 416
29 PAIN IN EXTREMITY 412
30 PNEUMONIA 396
31 RASH 392
32 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 373
33 CONSTIPATION 369
34 ABDOMINAL PAIN UPPER 359
35 HYPOGLYCAEMIA 356
36 COUGH 354
37 MYOCARDIAL INFARCTION 354
38 RENAL FAILURE 354
39 DRUG DOSE OMISSION 347
40 ANAEMIA 324
41 BACK PAIN 321
42 URINARY TRACT INFECTION 318
43 ABDOMINAL DISCOMFORT 312
44 PRODUCT USE ISSUE 312
45 GLYCOSYLATED HAEMOGLOBIN INCREASED 311
46 CEREBROVASCULAR ACCIDENT 310
47 INCORRECT DOSE ADMINISTERED 310
48 INSOMNIA 300
49 BLOOD PRESSURE INCREASED 288
50 HYPERGLYCAEMIA 287
51 PYREXIA 280
52 GASTROOESOPHAGEAL REFLUX DISEASE 274
53 DEHYDRATION 273
54 CHEST PAIN 270
55 SOMNOLENCE 265
56 ANXIETY 263
57 DIABETES MELLITUS 259
58 FEELING ABNORMAL 259
59 BLOOD GLUCOSE ABNORMAL 256
60 BLOOD GLUCOSE DECREASED 251
61 HYPERKALAEMIA 249
62 WEIGHT INCREASED 248
63 CHRONIC KIDNEY DISEASE 242
64 INJECTION SITE PAIN 240
65 CONDITION AGGRAVATED 239
66 HYPOTENSION 237
67 DEPRESSION 236
68 GAIT DISTURBANCE 233
69 MYALGIA 226
70 PRODUCT DOSE OMISSION 217
71 DIABETIC KETOACIDOSIS 215
72 DRUG INTERACTION 214
73 HYPERHIDROSIS 212
74 PANCREATIC CARCINOMA METASTATIC 212
75 MUSCLE SPASMS 209
76 PERIPHERAL SWELLING 208
77 HYPOAESTHESIA 200
78 ADVERSE EVENT 199
79 DYSPEPSIA 199
80 DYSPHAGIA 193
81 METASTASES TO LIVER 192
82 OVERDOSE 192
83 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 192
84 ASTHMA 191
85 FLUSHING 184
86 PARAESTHESIA 182
87 CONFUSIONAL STATE 180
88 OEDEMA PERIPHERAL 177
89 NASOPHARYNGITIS 176
90 VISION BLURRED 176
91 PRODUCT QUALITY ISSUE 174
92 PANCREATITIS ACUTE 173
93 DRUG HYPERSENSITIVITY 172
94 NEUROPATHY PERIPHERAL 168
95 URTICARIA 168
96 ERYTHEMA 167
97 RENAL IMPAIRMENT 167
98 MEMORY IMPAIRMENT 166
99 ABDOMINAL DISTENSION 165
100 VISUAL IMPAIRMENT 163
101 LOSS OF CONSCIOUSNESS 161
102 ALOPECIA 160
103 TYPE 2 DIABETES MELLITUS 159
104 SEPSIS 155
105 TREMOR 153
106 MUSCULAR WEAKNESS 148
107 BLOOD CREATININE INCREASED 144
108 HYPERSENSITIVITY 143
109 CHOLELITHIASIS 141
110 METABOLIC ACIDOSIS 141
111 PALPITATIONS 141
112 FLATULENCE 140
113 NEPHROLITHIASIS 138
114 CARDIAC DISORDER 136
115 GASTROINTESTINAL DISORDER 136
116 ATRIAL FIBRILLATION 135
117 GENERAL PHYSICAL HEALTH DETERIORATION 135
118 HAEMOGLOBIN DECREASED 134
119 THROMBOCYTOPENIA 134
120 COVID-19 133
121 HEART RATE INCREASED 132
122 INFLUENZA 132
123 CARDIAC ARREST 129
124 DRY MOUTH 129
125 BALANCE DISORDER 128
126 BLOOD CHOLESTEROL INCREASED 124
127 BLOOD GLUCOSE FLUCTUATION 123
128 PRODUCT USE IN UNAPPROVED INDICATION 121
129 INTENTIONAL PRODUCT MISUSE 120
130 FEELING HOT 118
131 CATARACT 117
132 SINUSITIS 116
133 CARDIAC FAILURE CONGESTIVE 113
134 CONTUSION 113
135 HYPERLIPIDAEMIA 113
136 OROPHARYNGEAL PAIN 113
137 RENAL DISORDER 113
138 BLADDER CANCER 112
139 OSTEOARTHRITIS 112
140 ARTHRITIS 111
141 HYPONATRAEMIA 111
142 POLLAKIURIA 111
143 RENAL FAILURE ACUTE 111
144 STRESS 111
145 HEPATIC STEATOSIS 108
146 SYNCOPE 105
147 TACHYCARDIA 105
148 ADENOCARCINOMA PANCREAS 104
149 CARDIAC FAILURE 103
150 INFECTION 103
151 FUNGAL INFECTION 101
152 GASTROINTESTINAL HAEMORRHAGE 101
153 HEPATIC ENZYME INCREASED 101
154 INTENTIONAL PRODUCT USE ISSUE 100
155 PLATELET COUNT DECREASED 100
156 JOINT SWELLING 99
157 PSORIASIS 99
158 DYSURIA 98
159 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 95
160 PLEURAL EFFUSION 94
161 BRONCHITIS 93
162 CHILLS 91
163 LIPASE INCREASED 91
164 VERTIGO 91
165 HOSPITALISATION 89
166 SLEEP APNOEA SYNDROME 89
167 PULMONARY EMBOLISM 86
168 SEIZURE 86
169 SURGERY 85
170 TOXICITY TO VARIOUS AGENTS 85
171 AMNESIA 83
172 CELLULITIS 83
173 MUSCULOSKELETAL PAIN 83
174 BLOOD PRESSURE DECREASED 82
175 BRADYCARDIA 82
176 BURNING SENSATION 82
177 CHEST DISCOMFORT 82
178 HAEMATURIA 82
179 INJECTION SITE HAEMORRHAGE 82
180 ANGIOEDEMA 81
181 PULMONARY MASS 81
182 RENAL CYST 81
183 SEPTIC SHOCK 81
184 UNDERDOSE 81
185 SWELLING 80
186 INABILITY TO AFFORD MEDICATION 78
187 OXYGEN SATURATION DECREASED 78
188 PANCYTOPENIA 78
189 CORONARY ARTERY DISEASE 77
190 DRUG INTOLERANCE 77
191 HOT FLUSH 77
192 INJECTION SITE ERYTHEMA 77
193 CHOLECYSTECTOMY 76
194 HAEMATOCHEZIA 76
195 INJECTION SITE PRURITUS 76
196 KETOACIDOSIS 76
197 NASAL CONGESTION 76
198 WRONG TECHNIQUE IN DRUG USAGE PROCESS 76
199 HYPOTHYROIDISM 75
200 NEUTROPENIA 75
201 PRODUCTIVE COUGH 75
202 RHINORRHOEA 75
203 SPEECH DISORDER 75
204 HYPOKALAEMIA 74
205 SLEEP DISORDER 74
206 COMA 73
207 EPISTAXIS 73
208 INFLUENZA LIKE ILLNESS 73
209 RESPIRATORY FAILURE 73
210 THROMBOSIS 73
211 TRANSIENT ISCHAEMIC ATTACK 73
212 DEEP VEIN THROMBOSIS 72
213 GASTRITIS 72
214 LUNG DISORDER 72
215 LYMPHADENOPATHY 72
216 DYSGEUSIA 71
217 RHABDOMYOLYSIS 71
218 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 71
219 EMOTIONAL DISTRESS 70
220 MEDICATION RESIDUE PRESENT 70
221 ARRHYTHMIA 69
222 DRY SKIN 69
223 GASTRIC DISORDER 69
224 GOUT 69
225 HAEMORRHAGE 69
226 NECK PAIN 69
227 WHEEZING 69
228 HALLUCINATION 68
229 MUSCULOSKELETAL STIFFNESS 68
230 FLUID RETENTION 67
231 DIABETIC NEUROPATHY 66
232 WHITE BLOOD CELL COUNT DECREASED 66
233 HEPATIC CIRRHOSIS 65
234 RHEUMATOID ARTHRITIS 65
235 ARTHROPATHY 64
236 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 63
237 HEPATIC FAILURE 63
238 LIVER DISORDER 63
239 METASTASES TO LUNG 63
240 NERVOUSNESS 63
241 TUBULOINTERSTITIAL NEPHRITIS 63
242 NEOPLASM MALIGNANT 62
243 PRODUCT SUBSTITUTION ISSUE 62
244 DISCOMFORT 61
245 PULMONARY OEDEMA 61
246 RASH PRURITIC 61
247 BREAST CANCER 60
248 ERECTILE DYSFUNCTION 60
249 METASTASES TO LYMPH NODES 60
250 MOBILITY DECREASED 60
251 MOVEMENT DISORDER 60
252 SWELLING FACE 60
253 URINARY INCONTINENCE 60
254 DYSPHONIA 59
255 PRODUCT PHYSICAL ISSUE 59
256 SPINAL OSTEOARTHRITIS 59
257 EUGLYCAEMIC DIABETIC KETOACIDOSIS 58
258 HAEMORRHOIDS 58
259 INJECTION SITE BRUISING 58
260 LETHARGY 58
261 RECTAL HAEMORRHAGE 58
262 TREATMENT NONCOMPLIANCE 58
263 ATELECTASIS 57
264 OEDEMA 57
265 PRODUCT AVAILABILITY ISSUE 57
266 ASCITES 56
267 BLOOD TRIGLYCERIDES INCREASED 56
268 BONE PAIN 56
269 HEPATITIS 56
270 PANCREATITIS CHRONIC 56
271 STOMATITIS 56
272 DRUG ADMINISTRATION ERROR 55
273 EXPIRED PRODUCT ADMINISTERED 55
274 INJECTION SITE MASS 55
275 MALIGNANT NEOPLASM PROGRESSION 55
276 SKIN LESION 55
277 HEPATOCELLULAR INJURY 54
278 ILLNESS 54
279 IMPAIRED GASTRIC EMPTYING 54
280 INTERSTITIAL LUNG DISEASE 54
281 ALANINE AMINOTRANSFERASE INCREASED 53
282 ANGINA PECTORIS 53
283 BLINDNESS 53
284 BLOOD PRESSURE FLUCTUATION 53
285 DIVERTICULUM 53
286 DIVERTICULUM INTESTINAL 53
287 ILL-DEFINED DISORDER 53
288 PRODUCT PRESCRIBING ERROR 53
289 DIVERTICULITIS 52
290 DIABETIC COMPLICATION 51
291 DISEASE PROGRESSION 51
292 EYE PAIN 51
293 FEBRILE NEUTROPENIA 51
294 HYPERCHOLESTEROLAEMIA 51
295 HYPOACUSIS 51
296 INJECTION SITE NODULE 51
297 URINARY RETENTION 51
298 BLISTER 50
299 CYSTITIS 50
300 PEMPHIGOID 50
301 SKIN DISORDER 50
302 SKIN EXFOLIATION 50
303 ADVERSE DRUG REACTION 49
304 GALLBLADDER DISORDER 49
305 JAUNDICE 49
306 ASPARTATE AMINOTRANSFERASE INCREASED 48
307 LOWER RESPIRATORY TRACT INFECTION 48
308 RASH ERYTHEMATOUS 48
309 RASH GENERALISED 48
310 SHOCK 48
311 WHITE BLOOD CELL COUNT INCREASED 48
312 DEVICE ISSUE 47
313 EYE DISORDER 47
314 MIGRAINE 47
315 PRODUCT DISPENSING ERROR 47
316 THERAPEUTIC RESPONSE UNEXPECTED 47
317 DYSPNOEA EXERTIONAL 46
318 GLAUCOMA 46
319 LEUKOCYTOSIS 46
320 NIGHT SWEATS 46
321 TINNITUS 46
322 ABNORMAL LOSS OF WEIGHT 45
323 ACUTE MYOCARDIAL INFARCTION 45
324 BLOOD POTASSIUM DECREASED 45
325 ECZEMA 45
326 GAIT INABILITY 45
327 GAMMA-GLUTAMYLTRANSFERASE INCREASED 45
328 GASTRIC ULCER 45
329 HIATUS HERNIA 45
330 HYPERTENSIVE CRISIS 45
331 HYPOPHAGIA 45
332 INFLAMMATION 45
333 INTERVERTEBRAL DISC PROTRUSION 45
334 LIMB DISCOMFORT 45
335 PANCREATICODUODENECTOMY 45
336 POOR QUALITY PRODUCT ADMINISTERED 45
337 SKIN DISCOLOURATION 45
338 LOCALISED INFECTION 44
339 MELAENA 44
340 STENT PLACEMENT 44
341 THERAPY CESSATION 44
342 ACCIDENTAL OVERDOSE 43
343 AGITATION 43
344 EATING DISORDER 43
345 HYPOMAGNESAEMIA 43
346 IRRITABILITY 43
347 PERIPHERAL COLDNESS 43
348 SKIN BURNING SENSATION 43
349 CARDIO-RESPIRATORY ARREST 42
350 DEPRESSED MOOD 42
351 END STAGE RENAL DISEASE 42
352 ERUCTATION 42
353 HYPOXIA 42
354 RENAL INJURY 42
355 THROAT IRRITATION 42
356 BLOOD PRESSURE ABNORMAL 41
357 DRY EYE 41
358 FULL BLOOD COUNT ABNORMAL 41
359 HEAD INJURY 41
360 LIMB INJURY 41
361 PRODUCT PRESCRIBING ISSUE 41
362 PRURITUS GENERALISED 41
363 RENAL TUBULAR NECROSIS 41
364 SUBDURAL HAEMATOMA 41
365 THERAPY INTERRUPTED 41
366 CEREBRAL HAEMORRHAGE 40
367 CORONARY ARTERY OCCLUSION 40
368 DEMENTIA 40
369 GASTROENTERITIS VIRAL 40
370 INJECTION SITE SWELLING 40
371 MALNUTRITION 40
372 METASTASES TO PERITONEUM 40
373 THIRST 40
374 THYROID CANCER 40
375 BLOOD URINE PRESENT 39
376 CHOLESTASIS 39
377 DIABETIC METABOLIC DECOMPENSATION 39
378 DISTURBANCE IN ATTENTION 39
379 EOSINOPHILIA 39
380 FREQUENT BOWEL MOVEMENTS 39
381 HYPERLACTACIDAEMIA 39
382 HYPERSOMNIA 39
383 ISCHAEMIC STROKE 39
384 LARGE INTESTINE POLYP 39
385 LIP SWELLING 39
386 LIVER FUNCTION TEST ABNORMAL 39
387 RADIOTHERAPY 39
388 AMYLASE INCREASED 38
389 BILE DUCT STENT INSERTION 38
390 BLOOD MAGNESIUM DECREASED 38
391 BLOOD PRESSURE SYSTOLIC INCREASED 38
392 HERPES ZOSTER 38
393 HIP FRACTURE 38
394 LUNG NEOPLASM MALIGNANT 38
395 OSTEOPOROSIS 38
396 PROSTATE CANCER 38
397 UNEVALUABLE EVENT 38
398 INJURY 37
399 PRODUCT PACKAGING QUANTITY ISSUE 37
400 RESPIRATORY DISORDER 37
401 AGGRESSION 36
402 BENIGN PROSTATIC HYPERPLASIA 36
403 BLOOD CREATINE PHOSPHOKINASE INCREASED 36
404 DIPLOPIA 36
405 DYSSTASIA 36
406 HEART RATE IRREGULAR 36
407 IRON DEFICIENCY ANAEMIA 36
408 OSTEOMYELITIS 36
409 PNEUMONITIS 36
410 PRESYNCOPE 36
411 PSORIATIC ARTHROPATHY 36
412 ROAD TRAFFIC ACCIDENT 36
413 ACUTE RESPIRATORY FAILURE 35
414 BLOOD POTASSIUM INCREASED 35
415 CHOKING 35
416 DISORIENTATION 35
417 INTENTIONAL OVERDOSE 35
418 OCULAR HYPERAEMIA 35
419 POOR QUALITY SLEEP 35
420 TRANSAMINASES INCREASED 35
421 UPPER RESPIRATORY TRACT INFECTION 35
422 ARTERIOSCLEROSIS 34
423 BLOOD SODIUM DECREASED 34
424 COLITIS 34
425 COLITIS ULCERATIVE 34
426 DEAFNESS 34
427 EYE SWELLING 34
428 FEELING COLD 34
429 FOURNIER^S GANGRENE 34
430 HYSTERECTOMY 34
431 PERICARDIAL EFFUSION 34
432 PHARYNGITIS 34
433 RESPIRATORY DISTRESS 34
434 SUICIDE ATTEMPT 34
435 UPPER GASTROINTESTINAL HAEMORRHAGE 34
436 VISUAL ACUITY REDUCED 34
437 LABORATORY TEST ABNORMAL 33
438 MEDICATION ERROR 33
439 PANCREATIC NEOPLASM 33
440 PROSTATOMEGALY 33
441 STAPHYLOCOCCAL INFECTION 33
442 WOUND 33
443 AGEUSIA 32
444 AORTIC ARTERIOSCLEROSIS 32
445 APHASIA 32
446 ARTERIOSCLEROSIS CORONARY ARTERY 32
447 BLOOD COUNT ABNORMAL 32
448 BLOOD UREA INCREASED 32
449 CARPAL TUNNEL SYNDROME 32
450 CIRCULATORY COLLAPSE 32
451 COLD SWEAT 32
452 DRUG EFFECT INCOMPLETE 32
453 FAECES DISCOLOURED 32
454 FOOT FRACTURE 32
455 HEART RATE DECREASED 32
456 ORTHOSTATIC HYPOTENSION 32
457 PRESCRIBED OVERDOSE 32
458 PRODUCT DISTRIBUTION ISSUE 32
459 RESPIRATORY TRACT INFECTION 32
460 ABASIA 31
461 C-REACTIVE PROTEIN INCREASED 31
462 COAGULOPATHY 31
463 DELIRIUM 31
464 DEPRESSED LEVEL OF CONSCIOUSNESS 31
465 DEVICE MALFUNCTION 31
466 DRUG DISPENSING ERROR 31
467 DRUG EFFECT DECREASED 31
468 GLOMERULAR FILTRATION RATE DECREASED 31
469 IMPAIRED HEALING 31
470 INTESTINAL OBSTRUCTION 31
471 MENTAL DISORDER 31
472 NEPHROGENIC ANAEMIA 31
473 NOCTURIA 31
474 PARKINSON^S DISEASE 31
475 POLYURIA 31
476 PRESCRIBED UNDERDOSE 31
477 PRODUCT STORAGE ERROR 31
478 PULMONARY FIBROSIS 31
479 RED BLOOD CELL COUNT DECREASED 31
480 SKIN ULCER 31
481 UMBILICAL HERNIA 31
482 VITAMIN D DEFICIENCY 31
483 CORONAVIRUS INFECTION 30
484 EMPHYSEMA 30
485 EYE PRURITUS 30
486 FEELING JITTERY 30
487 HAEMATEMESIS 30
488 INFUSION RELATED REACTION 30
489 NODULE 30
490 PALLOR 30
491 PNEUMONIA ASPIRATION 30
492 RASH MACULO-PAPULAR 30
493 SPLENOMEGALY 30
494 TOE AMPUTATION 30
495 VENTRICULAR TACHYCARDIA 30
496 ARTERIAL OCCLUSIVE DISEASE 29
497 CATARACT OPERATION 29
498 CHOLECYSTITIS 29
499 CROHN^S DISEASE 29
500 DYSARTHRIA 29
501 EMOTIONAL DISORDER 29
502 ESSENTIAL HYPERTENSION 29
503 EYE IRRITATION 29
504 INFARCTION 29
505 INTERNATIONAL NORMALISED RATIO INCREASED 29
506 OBESITY 29
507 PANCREATIC CYST 29
508 PRODUCT RESIDUE PRESENT 29
509 SPLENECTOMY 29
510 SUICIDAL IDEATION 29
511 COLON CANCER 28
512 DRUG PRESCRIBING ERROR 28
513 ENCEPHALOPATHY 28
514 HAEMATOCRIT DECREASED 28
515 HEPATOMEGALY 28
516 HYPOGLYCAEMIC COMA 28
517 JOINT INJURY 28
518 MATERNAL EXPOSURE DURING PREGNANCY 28
519 METASTASES TO BONE 28
520 MIDDLE INSOMNIA 28
521 RASH MACULAR 28
522 RETCHING 28
523 ANKLE FRACTURE 27
524 ANURIA 27
525 DEVICE LEAKAGE 27
526 FEEDING DISORDER 27
527 HEPATIC LESION 27
528 HUNGER 27
529 LEUKOPENIA 27
530 LOCAL SWELLING 27
531 MENTAL IMPAIRMENT 27
532 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27
533 MULTIPLE SCLEROSIS RELAPSE 27
534 MUSCULOSKELETAL CHEST PAIN 27
535 PANCREATECTOMY 27
536 PLASMA CELL MYELOMA 27
537 POLYDIPSIA 27
538 PROTEINURIA 27
539 SMALL INTESTINAL OBSTRUCTION 27
540 THERAPEUTIC RESPONSE DECREASED 27
541 ULCER 27
542 WEIGHT FLUCTUATION 27
543 BILE DUCT OBSTRUCTION 26
544 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 26
545 HAEMORRHAGIC ANAEMIA 26
546 HERNIA 26
547 INJECTION SITE REACTION 26
548 KIDNEY INFECTION 26
549 LUNG INFECTION 26
550 PRODUCT SIZE ISSUE 26
551 SWOLLEN TONGUE 26
552 THERAPY NON-RESPONDER 26
553 THYROID DISORDER 26
554 TOOTHACHE 26
555 VIRAL INFECTION 26
556 VITAMIN B12 DEFICIENCY 26
557 ACCIDENT 25
558 ACUTE CORONARY SYNDROME 25
559 BLOOD ALKALINE PHOSPHATASE INCREASED 25
560 CARDIAC MURMUR 25
561 CARDIAC OPERATION 25
562 CARDIOVASCULAR DISORDER 25
563 DRUG ERUPTION 25
564 DYSKINESIA 25
565 EYE HAEMORRHAGE 25
566 FEMUR FRACTURE 25
567 GASTROENTERITIS 25
568 HYPOCALCAEMIA 25
569 LIVER INJURY 25
570 NIGHTMARE 25
571 PRODUCT USE COMPLAINT 25
572 PYELONEPHRITIS 25
573 SCIATICA 25
574 CARDIOMEGALY 24
575 CHROMATURIA 24
576 DYSLIPIDAEMIA 24
577 FEAR 24
578 HAEMATOMA 24
579 HAEMOPTYSIS 24
580 INSURANCE ISSUE 24
581 INTENTIONAL DOSE OMISSION 24
582 IRRITABLE BOWEL SYNDROME 24
583 LOWER LIMB FRACTURE 24
584 NEPHROPATHY 24
585 RESTLESS LEGS SYNDROME 24
586 RIB FRACTURE 24
587 ABDOMINAL PAIN LOWER 23
588 ABNORMAL DREAMS 23
589 ACCIDENTAL UNDERDOSE 23
590 BLOOD IRON DECREASED 23
591 BLOOD TEST ABNORMAL 23
592 CARDIOMYOPATHY 23
593 ELECTROLYTE IMBALANCE 23
594 EXTRA DOSE ADMINISTERED 23
595 EYE MOVEMENT DISORDER 23
596 FIBROMYALGIA 23
597 FLANK PAIN 23
598 HEMIPARESIS 23
599 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23
600 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23
601 PRODUCT SUPPLY ISSUE 23
602 TREATMENT FAILURE 23
603 TYPE 1 DIABETES MELLITUS 23
604 APHONIA 22
605 CARDIAC PACEMAKER INSERTION 22
606 CHOLECYSTITIS CHRONIC 22
607 DEMENTIA ALZHEIMER^S TYPE 22
608 ELECTROCARDIOGRAM QT PROLONGED 22
609 HELICOBACTER INFECTION 22
610 ILEUS 22
611 IMPAIRED WORK ABILITY 22
612 INJECTION SITE EXTRAVASATION 22
613 LYMPHOMA 22
614 METASTASIS 22
615 MUSCULOSKELETAL DISCOMFORT 22
616 NEOPLASM PROGRESSION 22
617 NERVOUS SYSTEM DISORDER 22
618 ORAL PAIN 22
619 PARALYSIS 22
620 PULMONARY HYPERTENSION 22
621 PULSE ABNORMAL 22
622 SNEEZING 22
623 THROAT TIGHTNESS 22
624 TOOTH DISORDER 22
625 UROSEPSIS 22
626 BACK DISORDER 21
627 BLOOD CHOLESTEROL ABNORMAL 21
628 BLOOD LACTIC ACID 21
629 CHOLANGITIS 21
630 COGNITIVE DISORDER 21
631 CONVULSION 21
632 CRYING 21
633 DERMATITIS ATOPIC 21
634 DUODENAL ULCER 21
635 GOITRE 21
636 HAIR COLOUR CHANGES 21
637 HEPATIC CANCER 21
638 HIP ARTHROPLASTY 21
639 INJURY ASSOCIATED WITH DEVICE 21
640 JOINT STIFFNESS 21
641 LIVER FUNCTION TEST INCREASED 21
642 METABOLIC ENCEPHALOPATHY 21
643 OSTEOPENIA 21
644 PANCREATITIS NECROTISING 21
645 PERIPHERAL VASCULAR DISORDER 21
646 PRODUCT DOSE OMISSION IN ERROR 21
647 PRODUCT TASTE ABNORMAL 21
648 PROSTATIC SPECIFIC ANTIGEN INCREASED 21
649 RASH PAPULAR 21
650 RESTLESSNESS 21
651 ROTATOR CUFF SYNDROME 21
652 SINUS DISORDER 21
653 SKIN CANCER 21
654 TASTE DISORDER 21
655 THERAPEUTIC PRODUCT EFFECT DECREASED 21
656 ABNORMAL FAECES 20
657 ABSCESS 20
658 ACNE 20
659 ANAEMIA VITAMIN B12 DEFICIENCY 20
660 BACTERAEMIA 20
661 BLOOD BILIRUBIN INCREASED 20
662 BLOOD LACTIC ACID INCREASED 20
663 CARDIOGENIC SHOCK 20
664 HAIR TEXTURE ABNORMAL 20
665 INGUINAL HERNIA 20
666 INTERVERTEBRAL DISC DEGENERATION 20
667 JAUNDICE CHOLESTATIC 20
668 KNEE ARTHROPLASTY 20
669 MENTAL STATUS CHANGES 20
670 MOOD ALTERED 20
671 MUSCLE ATROPHY 20
672 PAIN IN JAW 20
673 PRODUCT COLOUR ISSUE 20
674 RENAL FAILURE CHRONIC 20
675 RENAL PAIN 20
676 SHOCK HAEMORRHAGIC 20
677 STATUS EPILEPTICUS 20
678 TARDIVE DYSKINESIA 20
679 UPPER LIMB FRACTURE 20
680 URINE ABNORMALITY 20
681 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20
682 ACIDOSIS 19
683 ACTIVITIES OF DAILY LIVING IMPAIRED 19
684 APPENDICECTOMY 19
685 BACTERIAL INFECTION 19
686 BLOOD ALBUMIN DECREASED 19
687 CONTRAINDICATED PRODUCT ADMINISTERED 19
688 CORONARY ARTERY BYPASS 19
689 DERMATITIS BULLOUS 19
690 DEVICE RELATED INFECTION 19
691 DRUG DEPENDENCE 19
692 DYSPNOEA AT REST 19
693 FULL BLOOD COUNT DECREASED 19
694 GANGRENE 19
695 GASTROINTESTINAL MOTILITY DISORDER 19
696 GENERALISED OEDEMA 19
697 HYPOVOLAEMIA 19
698 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19
699 INFUSION SITE PAIN 19
700 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 19
701 MUSCULOSKELETAL DISORDER 19
702 OESOPHAGITIS 19
703 PANCREATIC DISORDER 19
704 PANCREATIC MASS 19
705 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 19
706 PNEUMOBILIA 19
707 PROCEDURAL PAIN 19
708 THERAPEUTIC RESPONSE SHORTENED 19
709 TOOTH FRACTURE 19
710 TOXIC SKIN ERUPTION 19
711 VARICOSE VEIN 19
712 ABDOMINAL HERNIA 18
713 ALTERED STATE OF CONSCIOUSNESS 18
714 ANAPHYLACTIC REACTION 18
715 ATRIOVENTRICULAR BLOCK 18
716 ATRIOVENTRICULAR BLOCK COMPLETE 18
717 BACK INJURY 18
718 BEDRIDDEN 18
719 BLINDNESS UNILATERAL 18
720 BLOOD THYROID STIMULATING HORMONE INCREASED 18
721 CEREBRAL HAEMATOMA 18
722 CEREBRAL INFARCTION 18
723 CHOLANGIOCARCINOMA 18
724 DEVICE OCCLUSION 18
725 DRUG-INDUCED LIVER INJURY 18
726 EAR INFECTION 18
727 EPILEPSY 18
728 GLYCOSYLATED HAEMOGLOBIN DECREASED 18
729 HAIR DISORDER 18
730 HEPATIC CYST 18
731 HYDRONEPHROSIS 18
732 LACRIMATION INCREASED 18
733 LIMB OPERATION 18
734 MULTI-ORGAN FAILURE 18
735 OBSTRUCTIVE AIRWAYS DISORDER 18
736 PAIN OF SKIN 18
737 PANIC ATTACK 18
738 PERICARDITIS 18
739 PLATELET COUNT INCREASED 18
740 POLYP 18
741 POOR VENOUS ACCESS 18
742 SINUS CONGESTION 18
743 TENDON RUPTURE 18
744 TRANSFUSION 18
745 VAGINAL HAEMORRHAGE 18
746 WITHDRAWAL SYNDROME 18
747 ABORTION SPONTANEOUS 17
748 ACCIDENTAL EXPOSURE TO PRODUCT 17
749 BODY HEIGHT DECREASED 17
750 CYTOKINE RELEASE SYNDROME 17
751 DIABETIC RETINOPATHY 17
752 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17
753 ECONOMIC PROBLEM 17
754 EPIGASTRIC DISCOMFORT 17
755 ESCHERICHIA URINARY TRACT INFECTION 17
756 EYE INFECTION 17
757 GASTRIC HAEMORRHAGE 17
758 GINGIVAL BLEEDING 17
759 HEPATITIS ACUTE 17
760 HYPOKINESIA 17
761 MALIGNANT ASCITES 17
762 METASTASES TO CENTRAL NERVOUS SYSTEM 17
763 MOUTH ULCERATION 17
764 POST PROCEDURAL COMPLICATION 17
765 PRODUCT ODOUR ABNORMAL 17
766 RENAL CANCER 17
767 SQUAMOUS CELL CARCINOMA 17
768 SUSPECTED COUNTERFEIT PRODUCT 17
769 TONSILLECTOMY 17
770 URINE OUTPUT DECREASED 17
771 ABNORMAL BEHAVIOUR 16
772 ADRENAL MASS 16
773 AGRANULOCYTOSIS 16
774 ANAL INCONTINENCE 16
775 ANGER 16
776 BLOOD TESTOSTERONE DECREASED 16
777 BONE DENSITY DECREASED 16
778 BOWEL MOVEMENT IRREGULARITY 16
779 CANDIDA INFECTION 16
780 CLOSTRIDIUM DIFFICILE INFECTION 16
781 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16
782 ENTERITIS 16
783 GASTRITIS EROSIVE 16
784 GASTROINTESTINAL TUBE INSERTION 16
785 HYPERLIPASAEMIA 16
786 INFUSION SITE SWELLING 16
787 KNEE OPERATION 16
788 LOW DENSITY LIPOPROTEIN INCREASED 16
789 LOWER GASTROINTESTINAL HAEMORRHAGE 16
790 LYMPHOCYTE COUNT DECREASED 16
791 MADAROSIS 16
792 MICTURITION URGENCY 16
793 MITRAL VALVE INCOMPETENCE 16
794 MUCOSAL INFLAMMATION 16
795 MYELODYSPLASTIC SYNDROME 16
796 MYOCARDIAL ISCHAEMIA 16
797 NERVE COMPRESSION 16
798 NERVE INJURY 16
799 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16
800 PSYCHOLOGICAL TRAUMA 16
801 QUALITY OF LIFE DECREASED 16
802 SPINAL OPERATION 16
803 STEVENS-JOHNSON SYNDROME 16
804 TACHYPNOEA 16
805 URINE KETONE BODY PRESENT 16
806 URINE OUTPUT INCREASED 16
807 VENOUS OCCLUSION 16
808 WOUND INFECTION 16
809 ANAPHYLACTIC SHOCK 15
810 ANHEDONIA 15
811 ANOSMIA 15
812 ASPIRATION 15
813 BLOOD CALCIUM DECREASED 15
814 CHOLECYSTITIS ACUTE 15
815 CYST 15
816 DECUBITUS ULCER 15
817 ERYSIPELAS 15
818 GASTROINTESTINAL PAIN 15
819 HEPATIC ENCEPHALOPATHY 15
820 HERNIA REPAIR 15
821 HYPERVENTILATION 15
822 IMMUNE-MEDIATED MYOSITIS 15
823 INCREASED APPETITE 15
824 MOOD SWINGS 15
825 OCULOGYRIC CRISIS 15
826 PARAESTHESIA ORAL 15
827 PHARYNGEAL OEDEMA 15
828 PHOTOPHOBIA 15
829 RED BLOOD CELL SEDIMENTATION RATE INCREASED 15
830 SKIN PLAQUE 15
831 SPINAL FRACTURE 15
832 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 15
833 THYROID NEOPLASM 15
834 TUMOUR INVASION 15
835 VITREOUS FLOATERS 15
836 BILE DUCT STENOSIS 14
837 BODY TEMPERATURE DECREASED 14
838 CAROTID ARTERY STENOSIS 14
839 CLOSTRIDIUM DIFFICILE COLITIS 14
840 COMPLETED SUICIDE 14
841 CONCUSSION 14
842 DERMATITIS ALLERGIC 14
843 DIABETIC NEPHROPATHY 14
844 DISEASE COMPLICATION 14
845 DRUG LEVEL INCREASED 14
846 EJECTION FRACTION DECREASED 14
847 HYPERCHLORHYDRIA 14
848 HYPOTHERMIA 14
849 IMMUNE THROMBOCYTOPENIA 14
850 INJECTION SITE INDURATION 14
851 MALABSORPTION 14
852 METASTATIC NEOPLASM 14
853 NECROTISING FASCIITIS 14
854 NEEDLE ISSUE 14
855 NEUTROPHIL COUNT DECREASED 14
856 NEUTROPHIL COUNT INCREASED 14
857 OBSTRUCTION GASTRIC 14
858 ORAL DISCOMFORT 14
859 SEASONAL ALLERGY 14
860 SENSORY DISTURBANCE 14
861 SPLENIC VEIN THROMBOSIS 14
862 SYSTEMIC LUPUS ERYTHEMATOSUS 14
863 THERAPY CHANGE 14
864 TONGUE DISORDER 14
865 VASCULAR GRAFT 14
866 WRONG DRUG ADMINISTERED 14
867 WRONG PRODUCT ADMINISTERED 14
868 ADRENAL INSUFFICIENCY 13
869 ANAEMIA OF CHRONIC DISEASE 13
870 AORTIC ANEURYSM 13
871 BILE DUCT STONE 13
872 BLOOD PHOSPHORUS INCREASED 13
873 BONE DISORDER 13
874 BRAIN NEOPLASM 13
875 CARDIAC FAILURE CHRONIC 13
876 CATHETERISATION CARDIAC 13
877 CELL DEATH 13
878 CORONARY ARTERIAL STENT INSERTION 13
879 CUTANEOUS VASCULITIS 13
880 DENTAL CARIES 13
881 DIALYSIS 13
882 DIZZINESS POSTURAL 13
883 DUODENITIS 13
884 EAR PAIN 13
885 ESCHERICHIA INFECTION 13
886 EXPOSURE DURING PREGNANCY 13
887 EYELID OEDEMA 13
888 FAILURE TO THRIVE 13
889 FRACTURE 13
890 GALLBLADDER OPERATION 13
891 GASTRIC CANCER 13
892 GASTROINTESTINAL CARCINOMA 13
893 GASTROINTESTINAL INFECTION 13
894 GASTROSTOMY 13
895 HAEMORRHAGIC STROKE 13
896 HEPATIC MASS 13
897 HYPERCALCAEMIA 13
898 HYPERKERATOSIS 13
899 HYPERTHYROIDISM 13
900 IMMOBILE 13
901 INCORRECT DOSAGE ADMINISTERED 13
902 INCORRECT DOSE ADMINISTERED BY DEVICE 13
903 INCORRECT PRODUCT STORAGE 13
904 INJECTION SITE URTICARIA 13
905 INJECTION SITE WARMTH 13
906 LIGAMENT SPRAIN 13
907 LUNG INFILTRATION 13
908 LUNG OPACITY 13
909 MENINGIOMA 13
910 MICROCYTIC ANAEMIA 13
911 MUCOUS STOOLS 13
912 NEURALGIA 13
913 ORAL CANDIDIASIS 13
914 PIGMENTATION DISORDER 13
915 PNEUMOCYSTIS JIROVECII PNEUMONIA 13
916 PRODUCT LABEL ISSUE 13
917 RESPIRATORY SYMPTOM 13
918 SCAR 13
919 SCRATCH 13
920 SHOULDER OPERATION 13
921 SINUS TACHYCARDIA 13
922 SKIN IRRITATION 13
923 SKIN MASS 13
924 SUPRAVENTRICULAR TACHYCARDIA 13
925 TOOTH LOSS 13
926 UTERINE LEIOMYOMA 13
927 UVEITIS 13
928 ABDOMINAL MASS 12
929 ADRENAL ADENOMA 12
930 ANTI FACTOR V ANTIBODY 12
931 AORTIC STENOSIS 12
932 ATRIAL FLUTTER 12
933 BACTERIAL TEST POSITIVE 12
934 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 12
935 BILIARY DILATATION 12
936 BLADDER DISORDER 12
937 BLOOD CALCIUM INCREASED 12
938 BLOOD LACTATE DEHYDROGENASE INCREASED 12
939 BREAST CANCER METASTATIC 12
940 BREAST MASS 12
941 CARDIAC FAILURE ACUTE 12
942 CHRONIC GASTRITIS 12
943 CYTOPENIA 12
944 DERMATITIS 12
945 DIABETIC FOOT 12
946 DIABETIC HYPEROSMOLAR COMA 12
947 DISEASE RECURRENCE 12
948 DRUG LEVEL ABOVE THERAPEUTIC 12
949 DRY THROAT 12
950 ENCEPHALITIS 12
951 EYE INFLAMMATION 12
952 FOOD POISONING 12
953 GASTRIC POLYPS 12
954 HAEMOLYTIC ANAEMIA 12
955 HALLUCINATION, VISUAL 12
956 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12
957 INCORRECT DRUG ADMINISTRATION DURATION 12
958 INFUSION SITE WARMTH 12
959 INJECTION SITE HAEMATOMA 12
960 INJECTION SITE RASH 12
961 INTERNAL HAEMORRHAGE 12
962 INTRA-ABDOMINAL HAEMORRHAGE 12
963 IRON DEFICIENCY 12
964 JOINT EFFUSION 12
965 LARYNGITIS 12
966 LUNG DIFFUSION TEST DECREASED 12
967 MULTIPLE ALLERGIES 12
968 MULTIPLE SCLEROSIS 12
969 MYOSITIS 12
970 NEUTROPHILIA 12
971 PANCREATIC ENZYMES INCREASED 12
972 PETECHIAE 12
973 PNEUMOTHORAX 12
974 POISONING 12
975 PRE-EXISTING CONDITION IMPROVED 12
976 PURPURA 12
977 RENAL FUNCTION TEST ABNORMAL 12
978 RESPIRATORY ARREST 12
979 RETINAL HAEMORRHAGE 12
980 SENSORY LOSS 12
981 SKIN FISSURES 12
982 SPUTUM DISCOLOURED 12
983 VAGINAL INFECTION 12
984 VASCULITIS 12
985 VIITH NERVE PARALYSIS 12
986 VULVOVAGINAL MYCOTIC INFECTION 12
987 VULVOVAGINAL PRURITUS 12
988 ABDOMINAL ABSCESS 11
989 ABDOMINAL TENDERNESS 11
990 ACUTE PULMONARY OEDEMA 11
991 ANGINA UNSTABLE 11
992 ANGIOPLASTY 11
993 ANION GAP ABNORMAL 11
994 APATHY 11
995 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11
996 BALANOPOSTHITIS 11
997 BLOOD PRESSURE INADEQUATELY CONTROLLED 11
998 BONE MARROW OEDEMA 11
999 CONGENITAL GREAT VESSEL ANOMALY 11